Story perspectives

GLP-1 Drugs May Curb Alcohol Intake, Study Finds

10/20/2025

43 3

Summary

Story summary

Glucagon-like peptide-1 (GLP-1) drugs such as semaglutide and tirzepatide may reduce alcohol consumption by slowing absorption and diminishing intoxication.
A Virginia Tech study with 20 adults found those on GLP-1 medications reported feeling less drunk after the same amount of alcohol, suggesting changes in brain response and how the body processes alcohol.
Researchers advocate for larger trials to determine whether these medications could serve as therapies for reducing alcohol use.

1 of 1

Story summary

Glucagon-like peptide-1 (GLP-1) drugs such as semaglutide and tirzepatide may reduce alcohol consumption by slowing absorption and diminishing intoxication.
A Virginia Tech study with 20 adults found those on GLP-1 medications reported feeling less drunk after the same amount of alcohol, suggesting changes in brain response and how the body processes alcohol.
Researchers advocate for larger trials to determine whether these medications could serve as therapies for reducing alcohol use.